Condition

Glucose, High Blood

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 19 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials19
Recruiting1
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

19 shown
Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast CancerNCT03784651 · 2018-12-17
RECRUITING
The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose LevelsNCT05215210 · 2022-03-23
COMPLETED
Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention ProgramsNCT05056376 · 2021-10-01
COMPLETED
Continuous Glucose Monitoring of Hospitalized Patients With DiabetesNCT04230694 · 2021-09-20
COMPLETED
The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan FastingNCT05071950 · 2021-03-10
COMPLETED
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in PregnancyNCT04547023 · 2020-11-02
COMPLETED
Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work EnvironmentNCT04641689 · 2020-10-21
UNKNOWN
Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate WaterNCT04632277 · 2020-08-25
COMPLETED
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DMNCT04438018 · 2020-07-01
COMPLETED
Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 DiabetesNCT04893148 · 2020-05-26
UNKNOWN
The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant RecipientsNCT03685773 · 2019-04-21
WITHDRAWN
Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DMNCT03544411 · 2018-07-02
COMPLETED
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)NCT03811132 · 2018-07-01
COMPLETED
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to DiazoxideNCT03566511 · 2018-06-12
TERMINATED
Hydration to Optimize MetabolismNCT03422848 · 2018-04-24
COMPLETED
The TCF7L2 Gene: Dietary Prevention of T2DMNCT03458494 · 2018-02-15
TERMINATED
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRCNCT03428295 · 2017-06-22
SUSPENDED
Microclinic Social Network Behavioral Health Trial in JordanNCT01818674 · 2012-01-01
COMPLETED
Central Mechanisms That Regulate Glucose Metabolism in HumansNCT01028846 · 2006-11-02
TERMINATED

Common interventions

Trial status mix

COMPLETED11
TERMINATED3
UNKNOWN2
RECRUITING1
SUSPENDED1
WITHDRAWN1

Phase mix

NA10
PHASE23
PHASE12
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.